The manager <a href=" http://ziplinegear.biz/write-review-a-concert-for-me/ ">find college papers online bk</a> German drugmaker Merck KGaA will conduct new testson an experimental lung cancer vaccine which failed a previouslate-stage clinical trial, it said. The drug, licensed from U.S.biotech firm Oncothyreon, will be tested on patients withlocally advanced Stage III non-small cell lung cancer, whichcannot be surgically removed, unchanged from the previous trialcalled START, the firm said.
|